BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,523,860 | -14.0% | 93,372 | +3.8% | 0.01% | -11.1% |
| Q2 2023 | $4,097,438 | +12.4% | 89,935 | +0.0% | 0.01% | +12.5% |
| Q1 2023 | $3,646,831 | -15.7% | 89,912 | +5.9% | 0.01% | -27.3% |
| Q4 2022 | $4,327,965 | +6.2% | 84,912 | +12.2% | 0.01% | 0.0% |
| Q3 2022 | $4,075,000 | -16.7% | 75,658 | -0.7% | 0.01% | -8.3% |
| Q2 2022 | $4,893,000 | -55.4% | 76,179 | -46.1% | 0.01% | 0.0% |
| Q1 2022 | $10,960,000 | +97.4% | 141,352 | +118.6% | 0.01% | 0.0% |
| Q4 2021 | $5,552,000 | +25.1% | 64,665 | +17.2% | 0.01% | +9.1% |
| Q3 2021 | $4,439,000 | +55.8% | 55,189 | +56.0% | 0.01% | +37.5% |
| Q2 2021 | $2,849,000 | -2.9% | 35,388 | +1.6% | 0.01% | -20.0% |
| Q1 2021 | $2,935,000 | -7.6% | 34,814 | -12.1% | 0.01% | -16.7% |
| Q4 2020 | $3,177,000 | -33.7% | 39,599 | -33.6% | 0.01% | -50.0% |
| Q3 2020 | $4,794,000 | +1.7% | 59,614 | +8.8% | 0.02% | -14.3% |
| Q2 2020 | $4,716,000 | -2.7% | 54,778 | -8.2% | 0.03% | -26.3% |
| Q1 2020 | $4,845,000 | +9.2% | 59,663 | +12.4% | 0.04% | +35.7% |
| Q4 2019 | $4,437,000 | +16.3% | 53,058 | +21.6% | 0.03% | +3.7% |
| Q3 2019 | $3,816,000 | +2.8% | 43,626 | -3.8% | 0.03% | +8.0% |
| Q2 2019 | $3,712,000 | -1.3% | 45,334 | -2.1% | 0.02% | -7.4% |
| Q1 2019 | $3,762,000 | +71.8% | 46,327 | +39.2% | 0.03% | +35.0% |
| Q4 2018 | $2,190,000 | -15.1% | 33,271 | -0.6% | 0.02% | +5.3% |
| Q3 2018 | $2,580,000 | +614.7% | 33,477 | +583.8% | 0.02% | +280.0% |
| Q2 2018 | $361,000 | +24.5% | 4,896 | +9.8% | 0.01% | +25.0% |
| Q1 2018 | $290,000 | -17.1% | 4,458 | -17.4% | 0.00% | -20.0% |
| Q4 2017 | $350,000 | +9.0% | 5,397 | +5.3% | 0.01% | -16.7% |
| Q3 2017 | $321,000 | +22.1% | 5,126 | +16.8% | 0.01% | +20.0% |
| Q2 2017 | $263,000 | -27.9% | 4,388 | -37.6% | 0.01% | -28.6% |
| Q1 2017 | $365,000 | -66.3% | 7,029 | -70.7% | 0.01% | -75.0% |
| Q2 2016 | $1,083,000 | -39.3% | 23,968 | -44.8% | 0.03% | -41.7% |
| Q1 2016 | $1,783,000 | -4.1% | 43,407 | -10.9% | 0.05% | -21.3% |
| Q4 2015 | $1,859,000 | +22.6% | 48,713 | +5.6% | 0.06% | -1.6% |
| Q3 2015 | $1,516,000 | +567.8% | 46,132 | +1031.0% | 0.06% | +785.7% |
| Q2 2015 | $227,000 | -18.6% | 4,079 | 0.0% | 0.01% | -22.2% |
| Q1 2015 | $279,000 | – | 4,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |